Stock Track | Guardant Health Soars 5.28% in Pre-Market on Multiple Analyst Price Target Hikes

Stock Track02-20

Guardant Health Inc. (GH) shares surged 5.28% in pre-market trading, driven by a wave of positive analyst actions that included multiple price target increases from major financial firms.

The significant pre-market gain follows reports that several analyst firms have raised their price targets for Guardant Health. Stifel increased its target to $130 from $120, Leerink Partners raised to $180 from $170, Canaccord boosted to $135 from $125, JPMorgan and Barclays both raised to $130 from $120, BTIG increased to $145 from $140, and TD Cowen raised to $135 from $130.

These analyst actions reflect growing optimism about Guardant Health's prospects, with the company recently reporting quarterly revenue growth of 39.4% to $281.27 million, surpassing analyst expectations. The bullish sentiment is further supported by the current average analyst rating of "buy" with 23 "strong buy" or "buy" recommendations out of 26 total analyst ratings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163003302?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163003302","market":"hk","top_or_hot":-1,"title":"Stock Track | Guardant Health Soars 5.28% in Pre-Market on Multiple Analyst Price Target Hikes","media":"Stock Track","content":"<p>Guardant Health Inc. (GH) shares surged 5.28% in pre-market trading, driven by a wave of positive analyst actions that included multiple price target increases from major financial firms.</p><p>The significant pre-market gain follows reports that several analyst firms have raised their price targets for Guardant Health. Stifel increased its target to $130 from $120, Leerink Partners raised to $180 from $170, Canaccord boosted to $135 from $125, JPMorgan and Barclays both raised to $130 from $120, BTIG increased to $145 from $140, and TD Cowen raised to $135 from $130.</p><p>These analyst actions reflect growing optimism about Guardant Health's prospects, with the company recently reporting quarterly revenue growth of 39.4% to $281.27 million, surpassing analyst expectations. The bullish sentiment is further supported by the current average analyst rating of \"buy\" with 23 \"strong buy\" or \"buy\" recommendations out of 26 total analyst ratings.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Guardant Health Soars 5.28% in Pre-Market on Multiple Analyst Price Target Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Guardant Health Soars 5.28% in Pre-Market on Multiple Analyst Price Target Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guardant Health Inc. (GH) shares surged 5.28% in pre-market trading, driven by a wave of positive analyst actions that included multiple price target increases from major financial firms.</p><p>The significant pre-market gain follows reports that several analyst firms have raised their price targets for Guardant Health. Stifel increased its target to $130 from $120, Leerink Partners raised to $180 from $170, Canaccord boosted to $135 from $125, JPMorgan and Barclays both raised to $130 from $120, BTIG increased to $145 from $140, and TD Cowen raised to $135 from $130.</p><p>These analyst actions reflect growing optimism about Guardant Health's prospects, with the company recently reporting quarterly revenue growth of 39.4% to $281.27 million, surpassing analyst expectations. The bullish sentiment is further supported by the current average analyst rating of \"buy\" with 23 \"strong buy\" or \"buy\" recommendations out of 26 total analyst ratings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GH","symbol_name":"Guardant Health Inc.","start_time":0,"source_url":"","article_id":"1163003302","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163003302","pubTimestamp":1771596647,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Guardant Health Inc. (GH) shares surged 5.28% in pre-market trading, driven by a wave of positive analyst actions that included multiple price target increases from major financial firms.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GH":"Guardant Health Inc."},"translate_title":"个股追踪|Guardant Health盘前大涨5.28%因多位分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GH":1},"content_text":"Guardant Health Inc. (GH) shares surged 5.28% in pre-market trading, driven by a wave of positive analyst actions that included multiple price target increases from major financial firms.The significant pre-market gain follows reports that several analyst firms have raised their price targets for Guardant Health. Stifel increased its target to $130 from $120, Leerink Partners raised to $180 from $170, Canaccord boosted to $135 from $125, JPMorgan and Barclays both raised to $130 from $120, BTIG increased to $145 from $140, and TD Cowen raised to $135 from $130.These analyst actions reflect growing optimism about Guardant Health's prospects, with the company recently reporting quarterly revenue growth of 39.4% to $281.27 million, surpassing analyst expectations. The bullish sentiment is further supported by the current average analyst rating of \"buy\" with 23 \"strong buy\" or \"buy\" recommendations out of 26 total analyst ratings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163003302","isCrawlerRequest":true}